Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
607 MCGRAW trial: evaluation of the safety and efficacy of an oral microbiome intervention (SER-401) in combination with nivolumab in first line metastatic melanoma patients
Compose a Response to This Article
Other responses
No responses have been published for this article.